Related Experiment Videos
Platelet function in patients receiving enprostil
The American Journal of Medicine
|August 18, 1986
Summary
Neither enprostil nor ranitidine affected platelet function in patients with duodenal ulcers after 14 days of treatment. This study evaluated key platelet aggregation and coagulation markers during treatment.
Area of Science:
- Gastroenterology and Hematology
Background:
- Duodenal ulcers are common gastrointestinal conditions.
- Platelet function is crucial for hemostasis and can be affected by medications.
Purpose of the Study:
- To investigate the impact of enprostil and ranitidine on platelet function in duodenal ulcer patients.
- To compare the effects of these two common ulcer treatments on coagulation and platelet aggregation.
Main Methods:
- A double-blind, randomized, parallel study was conducted.
- Twenty-one patients with duodenal ulcers received either enprostil or ranitidine for 14 days.
- Platelet function was assessed using coagulation screens, aggregation tests, and plasma beta-thromboglobulin levels before and after treatment.
Main Results:
- No significant alterations in platelet function were observed with enprostil treatment.
- Ranitidine treatment also showed no effect on the assessed platelet function parameters.
- Both drugs were well-tolerated in terms of their impact on platelet activity.
Conclusions:
- Enprostil and ranitidine do not appear to adversely affect platelet function in patients with duodenal ulcers.
- These findings suggest that platelet aggregation and coagulation remain unaffected by short-term use of these medications in this patient population.